MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Spasticity: Treatment"

  • MDS Virtual Congress 2020

    Shear wave sonoelastography is effective in detecting myofascial trigger points and spasticity

    R. Bubnov, L. Kalika (Kyiv, Ukraine)

    Objective: The aim was to evaluate effectiveness of shear wave sonoelastography is effective in detecting myofascial trigger points (MTrP) and spasticity. Background: Ultrasound (US) revolutionized…
  • MDS Virtual Congress 2020

    Identification of Factors that Impact Adherence to OnabotulinumtoxinA Treatment for Spasticity in Post-Stroke and Multiple Sclerosis Patients from ASPIRE

    A. Esquenazi, W. Feng, G. Wittenberg, P. Gallien, A. Baricich, K. Fanning, A. Zuzek, G. Francisco, D. Bandari (Elkins Park, PA, USA)

    Objective: Identify baseline clinical characteristics and treatment-related factors that impact adherence to onabotulinumtoxinA (onabotA) treatment in post-stroke and multiple sclerosis (MS) patients from the Adult…
  • MDS Virtual Congress 2020

    Cost-Analysis of the Use of IncobotulinumtoxinA and AbobotulinumtoxinA for the Treatment of Post-Stroke Upper Limb Spasticity Based on Recommended Dosing for Muscles and Clinical Patterns

    M.E Gendron, D. Vézina (Burlington, ON, Canada)

    Objective: To carry out a cost-analysis based on the respective recommended dosing per muscle using IncobotulinumtoxinA (INCO) and AbobotulinumtoxinA (ABO) for the treatment of post-stroke…
  • MDS Virtual Congress 2020

    Perceptions of burden of spasticity and treatment satisfaction among post-stroke patients over the course of a botulinum neurotoxin A (BoNT-A) treatment cycle: An ethnographic study

    J. Jacinto, A. Lysandropoulos, A. Fulford-Smith (Estoril, Portugal)

    Objective: To design an ethnographic study following patients over a botulinum toxin type-A (BoNT-A) treatment cycle to inform individualized treatment. Background: The concept of individualized…
  • MDS Virtual Congress 2020

    Evaluating patient out-of-pocket (OOP) expenses using real world utilization data of botulinum toxins

    L. Turner-Stokes, A. Lysandropoulos, S. Wietek, C. Divers (Harrow, United Kingdom)

    Objective: The objective of this study was to evaluate the impact of different brands of botulinum neurotoxin type A (BoNT-A) on OOP patient spending based…
  • 2019 International Congress

    Influence of the spinal manipulation on muscle spasticity: a randomized controlled trial

    L. Shestopalova, T. Voloshyn (Truskavets, Ukraine)

    Objective: To assess how spinal manipulation influences muscle tone of the limbs Background: Muscle spasticity is an important clinical syndrome of many diseases, namely Parkinsons, post-stroke,…
  • 2019 International Congress

    Improvement of lower extremity Holmes tremor with intrathecal baclofen: First Report

    S. Saad, C. Kilbane, H. Abboud (Cleveland, OH, USA)

    Objective: OBJECTIVE: To describe a novel response of Atypical Holmes tremor to intrathecal baclofen (ITB). Background: Holmes tremor is a rare low-frequency high-amplitude tremor predominantly…
  • 2019 International Congress

    Inspiring Neurology Residents to Select Movement Disorders Fellowship Training

    K. Harper, T. Davis, F. Phibbs, PD. Charles (Nashville, TN, USA)

    Objective: To measure the impact of a junior resident education course focused on common movement disorders. Background: Focus on Common Movement Disorders is a two-day…
  • 2019 International Congress

    Symptomatic treatment of hereditary spastic paraplegias with fampridine: a pilot study

    M. Rosário, J. Ferreira, J. Ferro, L. Guedes (Lisbon, Portugal)

    Objective: Study the effect of fampridine in gait outcomes in patients with hereditary spastic paraplegia (HSP). Background: Fampridine acts through blockade of voltage-gated potassium channels,…
  • 2019 International Congress

    Disease-in-a-dish: drug discovery using patient-derived stem cells in Hereditary Spastic Paraplegia

    Y. Fan, G. Wali, R. Sutharsan, C. Sue, A. Mackay-Sim (Sydney, Australia)

    Objective: Identify a drug treatment for Hereditary Spastic Paraplegia (HSP) using patient-derived stem cell models Background: HSP is a neurological disorder characterised by axonal degeneration…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley